Elsevier

Neuroscience

Volume 66, Issue 2, May 1995, Pages 361-376
Neuroscience

Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

https://doi.org/10.1016/0306-4522(94)00606-6Get rights and content

Abstract

Striatal expression of preproenkephalin and preprotachykinin messenger RNA was studied in normal controls and in patients with Parkinson's disease using in situ hybridization histochemistry. In controls, preproenkaphalin messenger RNA was expressed in a population of medium-sized neurons of mean cross-sectional area 165 Ī¼m2, accounting for 66% of striatal medium-sized neurons, whereas preprotachykinin messenger RNA was expressed in a population of medium-sized neurons of mean cross-sectional area 204 Ī¼m2 (23% larger than those expressing enkephalin, P < 0.05), accounting for 58% of medium-sized striatal neurons. Much lower levels of both preproenkephalin messenger RNA and preprotachykinin messenger RNA were expressed by large neurons in the globus pallidus and substantia nigra reticulata. In addition, preproenkephalin messenger RNA was expressed at low levels by neurons in the subthalamic nucleus.

In Parkinson's disease cases, there was a statistically significant increase in preproenkephalin messenger RNA expression in the body of the caudate (109% increase, P < 0.05) and in the intermediolateral putamen (55% increase, P < 0.05) due to an increase in the level of gene expression per neuron rather than an increase in the number of neurons expressing preproenkephalin messenger RNA. Similar increases were observed in other putaminal subregions and in the putamen as a whole, but these did not reach statistical significance. No change in preprotachykinin messenger RNA expression was detected.

These findings demonstrate selective up-regulation of a striatal neuropeptide system in Parkinson's disease compatible with increased activity of the ā€œindirectā€ striatopallidal pathway, which is thought to play a crucial role in the pathophysiology of akinesia and rigidity in this condition.

References (108)

  • DackoS. et al.

    Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms

    Neurosci. Lett.

    (1991)
  • DeLongM.R.

    Primate models of movement disorders of basal ganglia origin

    Trends Neurosci.

    (1990)
  • EngberT.M. et al.

    Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin

    Brain Res.

    (1992)
  • EngberT.M. et al.

    Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

    Brain Res.

    (1991)
  • FernandezA. et al.

    Striatal neuropeptide levels in Parkinson's disease patients

    Neurosci. Lett.

    (1992)
  • FisherR.S. et al.

    Branched projections of pallidal and peripallidal neurons to neocortex and neostriatum: a duble-labelling study in the cat

    Brain Res.

    (1985)
  • GerfenC.R. et al.

    Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study

    Brain Res.

    (1988)
  • GravelandG.A. et al.

    The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum

    Brain Res.

    (1985)
  • GraybielA.M.

    Neurotransmitters and neuromodulators in the basal ganglia

    Trends Neurosci.

    (1990)
  • HaberS. et al.

    Correlation between met-enkephalin and substance P immunoreactivity in the primate globus pallidus

    Neuroscience

    (1981)
  • HaberS. et al.

    The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain

    Neuroscience

    (1985)
  • HarmarA.J. et al.

    cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A

    Fedn Eur. biochem. Socs Lett.

    (1986)
  • InghamC.A. et al.

    A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway

    Neuroscience

    (1991)
  • JayaramanA.

    Topographical organization and morphology of peripallidal and pallidal cells projecting to the striatum in cats

    Brain Res.

    (1983)
  • KanazawaI. et al.

    Evidence for the existence of substance P-containing fibres in the striato-nigral and pallido-nigral pathways in the rat brain

    Brain Res.

    (1977)
  • KingsburyA.E. et al.

    Tissue pH as an indicator of mRNA preservation in human post-mortem brain

    Molec. Brain Res.

    (1995)
  • MaiJ.K. et al.

    Substance P in the human brain

    Neuroscience

    (1986)
  • ManierM. et al.

    Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis

    Neuroscience

    (1991)
  • MauborgneA. et al.

    Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

    Brain Res.

    (1983)
  • MendezI.M. et al.

    Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts

    Expl Neurol.

    (1993)
  • NisbetA.P. et al.

    Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function

    Brain Res. molec. Brain Res.

    (1994)
  • NormandE. et al.

    Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons

    Brain Res.

    (1988)
  • ParentA.

    Extrinsic connections of the basal ganglia

    Trends Neurosci.

    (1990)
  • PennyG.R. et al.

    The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for a partial population overlap

    Neuroscience

    (1986)
  • Perez OtanoI. et al.

    Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset

    Brain Res.

    (1992)
  • PetrackB. et al.

    Increases in rat striatal preproenkephalin mRNA levels following chronic treatment with the depot neuroleptic, haloperidol decanoate

    Life Sci.

    (1990)
  • PollackA.E. et al.

    Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors

    Brain Res. molec. Brain Res.

    (1992)
  • PorrinoL.J. et al.

    Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate

    Life Sci.

    (1987)
  • SchneiderJ.S. et al.

    Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP

    Brain Res.

    (1987)
  • SivamS.P.

    Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem parkinsonian brains

    Neuropeptides

    (1991)
  • SivamS.P. et al.

    The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion

    Brain Res.

    (1990)
  • SmithY. et al.

    Differential connections of the caudate nucleus and putamen in the squirrel monkey. (Saimiri sciureus)

    Neuroscience

    (1986)
  • StainesW.A. et al.

    Demonstration of a pallidostriatal pathway by retrograde transport of HRP-labelled lectin

    Brain Res.

    (1981)
  • SzaboJ.

    Topical distribution of the striatal efferents in the monkey

    Expl. Neurol.

    (1962)
  • TaquetH. et al.

    Methionine enkephalin deficiency in brains of patients with Parkinson's disease

    Lancet

    (1981)
  • TaquetH. et al.

    Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain

    Brain Res.

    (1983)
  • TaquetH. et al.

    Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment

    Neuropeptides

    (1988)
  • TaylorM.D. et al.

    Effects of a unilateral 6-hydroxydopamine lesion and prolongedl-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia

    Eur. J. Pharmac.

    (1992)
  • TenovuoO. et al.

    Substance P immunoreactivity in the post-mortem parkinsonian brain

    Brain Res.

    (1984)
  • VeeningJ.G. et al.

    The topical organization of the afferents to the caudate putamen of the rat. A horseradish peroxidase study

    Neuroscience

    (1980)
  • Cited by (0)

    View full text